# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 03-31-2023 | 12-31-2022 | 10-K |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
ObsEva SA (NASDAQ:OBSV, SIX: OBSN))) today announced that it received a notification letter from The Nasdaq Stock Market LLC (...
ObsEva SA (NASDAQ:OBSV, SIX: OBSN)))), a biopharmaceutical company developing and commercializing novel therapies for women'...
Gainers Provention Bio, Inc. (NASDAQ: PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the c...
It is expected that Dr. Loumaye will serve in this position until the 2023 Annual General Meeting of Shareholders, at which tim...
It is expected that Dr. Loumaye will serve in this position until the 2023 Annual General Meeting of Shareholders, at which tim...
Gainers Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acq...
Gainers Fresh Tracks Therapeutics, Inc. (NASDAQ: FRTX) rose 51.1% to $2.66 in pre-market trading after the company disclosed...
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the di...
Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placem...